FRNM Freenome, Inc.
$14.37▼ -2.84%
Healthcare
Other
After hours
$14.65▲ +1.95%
Sep 11, 7:30 PM ET
Volume 535.4K
Avg Volume (10D) 903.9K
Key Metrics & Fundamentals
Market Cap
$1.54B
P/E Ratio
–
Div Yield
–%
52W Range
9.95 - 17.18
% vs 50 MA
17.81%
% vs 200 MA
22.09%
RSI-14
56.8
MACD Histogram
+0.0300
Beta (1Y vs SPY)
0.35
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Aug 17, 2026 8:02 PM
FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based SimpleScreen™ Lung Cancer Screening Test
GlobeNewswire · Aug 12, 2026 1:00 PM
Freenome (FRNM) Climbed, But What Is Driving Attention Now?
Simply Wall St. · Aug 11, 2026 3:19 AM
Guardant Health, Thursday's Stock Of The Day, Spikes After Hiking 2026 Outlook
Investor's Business Daily · Jul 31, 2026 8:22 PM
Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment
MT Newswires · Jul 27, 2026 12:50 PM
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
GlobeNewswire · Jul 27, 2026 12:00 PM
Freenome Closes Business Combination With Perceptive Capital Solutions
MT Newswires · Jul 20, 2026 8:56 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
No Reddit posts found for FRNM.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.